Who is sponsoring NCT07530991?

NCT07530991 is sponsored by Chris Jaynes.

What condition does NCT07530991 study?

NCT07530991 studies Normothermic Machine Perfusion (NMP) of Deceased Donor Kidneys.

Is NCT07530991 still recruiting?

NCT07530991 is currently active, enrolled. Last updated 15 April 2026.

Last reviewed 2026-04-15 · How we verify

NCT07530991

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Registry Analysis of Deceased Donor Kidney Transplant Outcomes

Active, enrolled Last updated 15 April 2026

What this trial tests

trial in Normothermic Machine Perfusion (NMP) of Deceased Donor Kidneys in 3,500 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 April 2026

Primary endpoint
30 April 2029

30 April 2029

Quick facts

Lead sponsor	Chris Jaynes
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	3,500
Start date	1 April 2026
Primary completion	30 April 2029
Estimated completion	30 April 2029
Sites	1 location across United States

Conditions studied

Normothermic Machine Perfusion (NMP) of Deceased Donor Kidneys — all drugs for Normothermic Machine Perfusion (NMP) of Deceased Donor Kidneys →

Sponsor

Chris Jaynes

Who can join

15 and older, any sex, with Normothermic Machine Perfusion (NMP) of Deceased Donor Kidneys. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study uses existing transplant data obtained from a national public donor registry operated by the Organ Procurement and Transplant Network (OPTN) under Health Resources and Services Agency (HRSA) to evaluate outcomes associated with normothermic machine perfusion (NMP) of deceased donor kidneys. Currently, there is no method to study NMP kidney outcomes using the National Scientific Registry for Transplant Recipients (SRTR) national public registry, because no data field exists to identify which kidneys received NMP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07530991 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chris Jaynes
Last refreshed: 15 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07530991.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing